ID   LBRM-33 clone 4A2
AC   CVCL_6490
SY   LBRM-33-4A2; LBRM-33 4A2; 4A2
DR   CLO; CLO_0007275
DR   ATCC; TIB-155
DR   Wikidata; Q54902117
RX   Patent=US4404280;
RX   PubMed=6968790;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: B10.BR.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_K174 ! LBRM-33
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
RX   Patent=US4404280;
RA   Gillis S.;
RT   "Process for preparing murine interleukin 2 in the presence of
RT   interleukin 1 from an interleukin 2 nonproducer malignant cell line
RT   and cell line therefor.";
RL   Patent number US4404280, 13-Sep-1983.
RX   PubMed=6968790; DOI=10.4049/jimmunol.125.6.2570;
RA   Gillis S., Scheid M.P., Watson J.;
RT   "Biochemical and biologic characterization of lymphocyte regulatory
RT   molecules. III. The isolation and phenotypic characterization of
RT   Interleukin-2 producing T cell lymphomas.";
RL   J. Immunol. 125:2570-2578(1980).